HuagongsheHuagongshe Chemie-Druckbericht · Nur für Forschungszwecke

HCID 115286Erstellt: 27. Oktober 2026

Phallisin

phallisin · Phallicin · Phalloidin, 7-(4,5,5'-trihydroxy-L-leucine)-

https://huagongshe.com/de/chemical/115286

Identifikatoren & physikalische Daten

CAS No.	19774-69-7
Summenformel	C35H48N8O12S
Durchschnittliche Molmasse	804,9 g/mol
Monoisotopische Masse	804,31123998 g/mol
SMILES	CC1NC(=O)C(CC(O)(CO)CO)NC(=O)C2Cc3c([nH]c4ccccc34)SCC(NC(=O)C(C(C)O)NC1=O)C(=O)N1CC(O)CC1C(=O)NC(C)C(=O)N2
InChIKey	SRDQDZSLNAKOIT-UHFFFAOYSA-N
PubChem CID	115286
DTXSID	DTXSID501046161

Chemische & physikalische Eigenschaften

XLogP	-2,7
Polarare Oberfläche (TPSA)	337
H-Brücken-Donoren	12
H-Brücken-Akzeptoren	13
Frei drehbare Bindungen	5
Schwere Atome	56
Formalladung	0
Komplexität	1.520
Siedepunkt	1444.1±65.0 °C(Predicted)
Dichte	1.55±0.1 g/cm3(Predicted)
pKa (Säurekonstante)	12.94±0.70(Predicted)

Sicherheit & Vorschriften

Treatment	Consider gastric lavage and activated charcoal. (A678)
Gesundheitliche Auswirkungen	Liver lesions, tachycardia, hypoglycemia, hypotension and electrolyte imbalance with acid- base disturbance (L1160).
Expositionspfade	Oral, dermal, inhalation, and parenteral (contaminated drugs). (A3101)
Toxizitätsübersicht	Phallotoxins bind actin, preventing its depolymerization and poisoning the cell. They bind specifically at the interface between F-actin subunits, locking adjacent subunits together. This leads to a decrease in the rate constant for the dissociation of actin subunits from filament ends, which essentially stabilizes actin filaments through the prevention of filament depolymerization. Moreover, they inhibit the ATP hydrolysis activity of F-actin. (L1183, A2465)
Signs and Symptoms	Hypovolemic shockGastrointestinal symptoms occur after a latent period and include abdominal pain, vomiting, and watery diarrhea. Neurologic symptoms are related to hepatic failure and may include encephalopathy, somnolence, confusion, coma and seizures (L1160).
Carcinogen Classification	No indication of carcinogenicity to humans (not listed by IARC).
Toxicity Data	LD50: 2 mg/kg (Mouse) (T258)

Identifikatoren & physikalische Daten

CAS No.

19774-69-7

Summenformel

C35H48N8O12S

Durchschnittliche Molmasse

804,9 g/mol

Monoisotopische Masse

804,31123998 g/mol

SMILES

CC1NC(=O)C(CC(O)(CO)CO)NC(=O)C2Cc3c([nH]c4ccccc34)SCC(NC(=O)C(C(C)O)NC1=O)C(=O)N1CC(O)CC1C(=O)NC(C)C(=O)N2

InChIKey

SRDQDZSLNAKOIT-UHFFFAOYSA-N

PubChem CID

115286

DTXSID

DTXSID501046161

XLogP

-2,7

Polarare Oberfläche (TPSA)

337

H-Brücken-Donoren

H-Brücken-Akzeptoren

Frei drehbare Bindungen

Schwere Atome

Formalladung

Komplexität

1.520

Siedepunkt

1444.1±65.0 °C(Predicted)

Dichte

1.55±0.1 g/cm3(Predicted)

pKa (Säurekonstante)

12.94±0.70(Predicted)

Sicherheit & Vorschriften

Treatment

Consider gastric lavage and activated charcoal. (A678)

Gesundheitliche Auswirkungen

Liver lesions, tachycardia, hypoglycemia, hypotension and electrolyte imbalance with acid- base disturbance (L1160).

Expositionspfade

Oral, dermal, inhalation, and parenteral (contaminated drugs). (A3101)

Toxizitätsübersicht

Phallotoxins bind actin, preventing its depolymerization and poisoning the cell. They bind specifically at the interface between F-actin subunits, locking adjacent subunits together. This leads to a decrease in the rate constant for the dissociation of actin subunits from filament ends, which essentially stabilizes actin filaments through the prevention of filament depolymerization. Moreover, they inhibit the ATP hydrolysis activity of F-actin. (L1183, A2465)

Signs and Symptoms

Hypovolemic shockGastrointestinal symptoms occur after a latent period and include abdominal pain, vomiting, and watery diarrhea. Neurologic symptoms are related to hepatic failure and may include encephalopathy, somnolence, confusion, coma and seizures (L1160).

Carcinogen Classification

No indication of carcinogenicity to humans (not listed by IARC).

Toxicity Data

LD50: 2 mg/kg (Mouse) (T258)